Herbert Y Meltzer

  • 69064 Citations
1961 …2022
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Herbert Y. Meltzer, MD, is Professor of Psychiatry and Behavioral Sciences, Pharmacology and Physiology and Director of the Translational Neuropharmacology Program at Northwestern University in Chicago, IL. He received his BA from Cornell University, an MA in Chemistry from Harvard, and his MD from Yale University. Dr. Meltzer has been President of the American College of Neuropsychopharmacology (ACNP) and the Collegium International Neuro-psychopharmacologicum (CINP). He was co-editor of the ACNP journal, Neuropsychopharmacology. Current research interests include: 1) development of novel drugs for treatment and prevention of psychosis, depression, opioid abuse, and age associated cognitive impairment; 2) behavioral and neurochemical studies of antipsychotic, antidepressant, cognitive improving, and antisuicide drugs; and 3) genetic biomarkers. Dr. Meltzer is the recipient of the Efron and Paul Hoch Awards of the ACNP, the Lieber Prize for Schizophrenia Research from NARSAD/Brain Behavior Research Foundation, the Dean Award for Research in Schizophrenia of the American College of Psychiatry, the Gold Medal Award of the Society of Biological Psychiatry, the Sutherland Prize for Research and Grant Liddle Award for Clinical Research of Vanderbilt University, the Research Prize of the American Psychiatric Association, and the Lifetime Achievement awards from the Schizophrenia International Research Society (SIRS).

Training Experience

1964Internship, Saint Luke's Hospital
1966Residency, Massachusetts Mental Health Center

Education/Academic qualification

MD, Yale University

… → 1963

Research interests

  • Clinical Research
  • Depression
  • Mental Health
  • Neuropsychology
  • Pharmacology
  • Physiology
  • Psychiatry
  • Schizophrenia

Fingerprint Dive into the research topics where Herbert Y Meltzer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Schizophrenia Medicine & Life Sciences
Antipsychotic Agents Medicine & Life Sciences
Clozapine Medicine & Life Sciences
Prolactin Medicine & Life Sciences
Serotonin Medicine & Life Sciences
Dopamine Medicine & Life Sciences
Psychotic Disorders Medicine & Life Sciences
olanzapine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2011 2022

Research Output 1961 2019

1 Citation (Scopus)

Activation of dopamine receptor 2 prompts transcriptomic and metabolic plasticity in glioblastoma

Caragher, S. P., Shireman, J. M., Huang, M., Miska, J., Atashi, F., Baisiwala, S., Park, C. H., Saathoff, M. R., Warnke, L., Xiao, T., Lesniak, M. S., David James, C., Meltzer, H., Tryba, A. K. & Ahmed, A. U., Mar 13 2019, In : Journal of Neuroscience. 39, 11, p. 1982-1993 12 p.

Research output: Contribution to journalArticle

Dopamine Receptors
Neurotransmitter Agents
Tumor Microenvironment
Antipsychotic Agents
Single Nucleotide Polymorphism
Receptor, Serotonin, 5-HT1A

Association of serotonin2C receptor polymorphisms with antipsychotic drug response in schizophrenia

Li, J., Hashimoto, H. & Meltzer, H. Y., Jan 1 2019, In : Frontiers in Psychiatry. 10, FEB, 58.

Research output: Contribution to journalArticle

Open Access
Antipsychotic Agents
Receptor, Serotonin, 5-HT2C
5 Citations (Scopus)

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia

Zai, C. C., Tiwari, A. K., Chowdhury, N. I., Yilmaz, Z., de Luca, V., Müller, D. J., Potkin, S. G., Lieberman, J. A., Meltzer, H. Y., Voineskos, A. N., Remington, G. & Kennedy, J. L., Jan 2 2019, In : World Journal of Biological Psychiatry. 20, 1, p. 91-95 5 p.

Research output: Contribution to journalArticle

Movement Disorders
Antipsychotic Agents
Single Nucleotide Polymorphism
2 Citations (Scopus)

Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain

Maciukiewicz, M., Gorbovskaya, I., Tiwari, A. K., Zai, C. C., Freeman, N., Meltzer, H. Y., Kennedy, J. L. & Müller, D. J., Jan 21 2019, In : Journal of Neural Transmission. 126, 1, p. 27-33 7 p.

Research output: Contribution to journalArticle

Class 2 Receptor-Like Protein Tyrosine Phosphatases
Validation Studies
Antipsychotic Agents
Weight Gain